Cooperative Agreement W81XWH0920186

The National Institute of Neurological Disorders and Stroke (NINDS), through the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853), awarded Versapeutics Inc. a $2,380,552 federal project grant on September 18, 2023 to conduct toxicology and efficacy studies of their novel antibody therapeutic Versamab-101 for treating spinal cord injury. Versapeutics, a for-profit biotechnology company, will utilize the funding to evaluate the safety profile and determine...

This Project Grant award from the Department of the Army Medical Command provides $3,940,561 to fund the "Breathing Low Oxygen to Enhance Spinal Stimulation Training and Functional Recovery in Persons with Chronic Spinal Cord Injury: The BO2ST Trial" project under the Military Medical Research and Development program (CFDA 12.420). The award period is from September 30, 2022 through September 29, 2026. The project aims to investigate the extent to which daily acute intermittent hypoxia...

This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports development of a novel screening technology to identify FDA-approved drugs that can promote functional recovery in spinal cord injury (SCI). The $411,136 award to the Texas A&M University System Health Science Center will fund a 3-step screening platform using adult cortical...

Teliatry Inc. received a $768,138 project grant award from the National Institutes of Health's National Institute of Biomedical Imaging and Bioengineering to develop a minimally invasive, single incision, rechargeable spinal cord stimulation system for chronic pain management. The grant was awarded under the Discovery and Applied Research for Technological Innovations to Improve Human Health program. Through this award, Teliatry will engineer the world's smallest (0.75cc), most cost-effective...

The Department of the Army Medical Command awarded a $539,979 project grant to Imperial College London under the Military Medical Research and Development program. The grant will fund research from August 2021 to August 2024 to develop a monoclonal antibody targeting CXCL13 to promote axonal plasticity, regeneration, and functional recovery after spinal cord injury. The Military Medical Research and Development program aims to transform military and public health through innovative medical...

This Project Grant award of $305,447, issued on September 2, 2024 by the National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research), aims to identify predictive biomarkers for acute intermittent hypoxia-induced motor recovery in individuals with incomplete spinal cord injury. The research team from the University of Colorado will: 1) Validate the cellular mechanisms underlying hypoxia-induced plasticity in humans, using...

This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $411,941 to Drexel University to conduct research on identifying novel trunk reflex pathways and how they differ after neonatal versus adult spinal cord injury in animal models. The key objectives are to test the hypothesis that the newly discovered contralateral monosynaptic trunk...

This federal Project Grant award, worth $2,966,875.00, was made by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports a prospective clinical trial to investigate the optimal timing of surgical decompression for patients with acute spinal cord injuries. The grant recipient, the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, will conduct the research at its facility in Torrance, California over a...

The federal Project Grant award of $1,793,411 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the Rehabilitation Institute of Chicago (doing business as Shirley Ryan AbilityLab), a non-profit hospital and research institute. The funding will support a research project titled "SAFETY AND EFFICACY OF AMPAKINES FOR IMPROVEMENT OF BLADDER FUNCTION IN INDIVIDUALS WITH SCI" over the period of July 1, 2024 to June 30,...

The Department of the Army Medical Command awarded a $711,403 project grant to The Children's Hospital Corporation (doing business as Boston Children's Hospital) under the Military Medical Research and Development program (CFDA 12.420). The grant supports a project titled "A Noninvasive Neurotrophic Factor Treatment to Repair the Injured Spinal Cord" with a period of performance from October 1, 2024 to September 30, 2027. This project grant supports advanced biomedical research focused...